The New York Mets face a complex decision in pursuing Tarik Skubal, a top-tier starting pitcher and two-time American League Cy Young Award winner, as they look to bolster their rotation ahead of the 2025 season. While Skubal represents a clear solution to the team’s need for an ace alongside Noah Syndergaard, uncertainties surrounding Major League Baseball’s future economic framework have complicated the Mets’ approach.
The current collective bargaining agreement expires on December 1, and there is widespread speculation that a new deal could introduce a salary cap or some form of spending limitations. Industry insiders generally believe any cap would not take effect until the 2028 or 2029 seasons, but with the Mets already committed to large contracts for Juan Soto and Francisco Lindor, adding Skubal’s potentially massive contract raises questions about long-term financial flexibility within a 26-man roster.
Skubal, who is approaching his 30th birthday and has undergone three elbow procedures, is viewed by many executives as the only guaranteed top-of-the-rotation free agent in this year’s market. Multiple league sources, speaking on condition of anonymity, emphasize that no other available starter outside Skubal has demonstrated clear playoff-caliber potential.
The Mets could also pursue rotation help through trades, though sources indicate the cost for such acquisitions remains high. Regardless of their pursuit of Skubal, the front office is expected to aggressively seek additional starting pitchers to improve depth, an area where the team has struggled in recent seasons. In 2024, injuries to key pitchers Griffin Canning and Clay Holmes exposed the rotation’s fragility, contributing to back-to-back missed playoff appearances.
David Stearns, the Mets’ president of baseball operations, acknowledged this shortcoming at an end-of-season press conference in September, stressing the need for more options and roster flexibility. Stearns highlighted the importance of developing pitchers internally while securing external talent to maintain a strong, adaptable rotation.
Comparisons to organizations like the Milwaukee Brewers and Tampa Bay Rays underscore the Mets’ aspiration to cultivate a system capable of supplying ready major league starters. This approach reflects lessons learned from the inconsistent performances of Sean Manaea, David Peterson, and Kodai Senga during the past season, which limited the Mets’ ability to maneuver roster decisions.
Skubal’s profile contrasts with pitchers like Freddy Peralta, who the Mets acquired last offseason but who ultimately found success only after being traded to the Rays. Stearns noted that the Rays’ developmental processes helped unlock Peralta’s potential in ways the Mets were unable to replicate, underscoring the difficulty of predicting pitching success.
While Stearns generally approaches long-term contracts for starting pitchers cautiously, exceptions are considered for elite talents like Skubal. However, any pursuit hinges on clarifying contractual demands, which may reach into the $400 million to $500 million range, and assessing how Skubal’s agent, Scott Boras, will navigate free agency amid the looming labor agreement deadline.
Questions remain about whether Skubal could sign before December 1, his preference among contending teams—including the Dodgers, who acquired him at the trade deadline—and whether the Mets will be willing to make such a significant financial commitment given the uncertainties ahead.
As the Mets weigh these factors, they understand that a failure to sign Skubal will require robust contingency plans. Front office executives recognize that securing additional pitching—both as a top-end starter and as depth—is essential to avoid a repeat of recent rotation vulnerabilities and to position the team for postseason contention.